Ke Qi | Searcharxiv

arXiv2021

Unified Batch All Triplet Loss for Visible-Infrared Person Re-identification

Visible-Infrared cross-modality person re-identification (VI-ReID), whose aim is to match person images between visible and infrared modality, is a challenging cross-modality image retrieval task. Batch Hard Triplet loss is widely used in person re-identification tasks, but it does not perform well in the Visible-Infrared person re-identification task. Because it only optimizes the hardest triplet for each anchor image within the mini-batch, samples in the hardest triplet may all belong to the same modality, which will lead to the imbalance problem of modality optimization. To address this problem, we adopt the batch all triplet selection strategy, which selects all the possible triplets among samples to optimize instead of the hardest triplet. Furthermore, we introduce Unified Batch All Triplet loss and Cosine Softmax loss to collaboratively optimize the cosine distance between image vectors. Similarly, we rewrite the Hetero Center Triplet loss, which is proposed for VI-ReID task, into a batch all form to improve model performance. Extensive experiments indicate the effectiveness of the proposed methods, which outperform state-of-the-art methods by a wide margin.

cs.CV↗

arXiv2020

The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge: Results after 1 Year Follow-up

We present the findings of "The Alzheimer's Disease Prediction Of Longitudinal Evolution" (TADPOLE) Challenge, which compared the performance of 92 algorithms from 33 international teams at predicting the future trajectory of 219 individuals at risk of Alzheimer's disease. Challenge participants were required to make a prediction, for each month of a 5-year future time period, of three key outcomes: clinical diagnosis, Alzheimer's Disease Assessment Scale Cognitive Subdomain (ADAS-Cog13), and total volume of the ventricles. The methods used by challenge participants included multivariate linear regression, machine learning methods such as support vector machines and deep neural networks, as well as disease progression models. No single submission was best at predicting all three outcomes. For clinical diagnosis and ventricle volume prediction, the best algorithms strongly outperform simple baselines in predictive ability. However, for ADAS-Cog13 no single submitted prediction method was significantly better than random guesswork. Two ensemble methods based on taking the mean and median over all predictions, obtained top scores on almost all tasks. Better than average performance at diagnosis prediction was generally associated with the additional inclusion of features from cerebrospinal fluid (CSF) samples and diffusion tensor imaging (DTI). On the other hand, better performance at ventricle volume prediction was associated with inclusion of summary statistics, such as the slope or maxima/minima of biomarkers. TADPOLE's unique results suggest that current prediction algorithms provide sufficient accuracy to exploit biomarkers related to clinical diagnosis and ventricle volume, for cohort refinement in clinical trials for Alzheimer's disease. However, results call into question the usage of cognitive test scores for patient selection and as a primary endpoint in clinical trials.

q-bio.PE↗